Site updated at Wednesday, 22 June 2016

Living with Dementia

Immune Globulin

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   

Out of the shadows - Living with dementia

movement disorders1 - cognitive1 - alzheimer's-related plaque1 - gene therapy1 - mental impairment1 - white matter hyperintensities1 - early signs of dementia1 - brain insulin1 - cyclophilin a1 - memory losses1 - mci7 - physical reality1 - sleep tied to alzheimer's1 - ophthalmoplegia4 - decline in memory1 - beta amyloid protein1 - thc1 - dementia community1 - carotid ultrasound1 - references1 - moderate severe decline1 - delirious episode1 - impassable plaques1 - cognitive abilities1 - csf1 - dementia resistant1 - micro-gliosis1 - alzheimer’s patients1 - beta secretase1 - tuberculosis1 -